MagnetisMM-32

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 18 by

Beverly Hills Cancer Center
Beverly Hills, CA
  • Accepting patients
WVU Cancer Institute
Mary Babb Randolph Cancer Center
Morgantown, WV
  • Accepting patients
Nebraska Hematology Oncology
Lincoln, NE
  • Accepting patients
Morristown Medical Center
Atlantic Health System
Morristown, NJ
  • Accepting patients
Infirmary Cancer Care
Mobile, AL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.